Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Abstract Text:

Nicolas Pottier,Meyling H Cheok,Wenjian Yang,Mahfoud Assem,Lorraine Tracey,John C Obenauer,John C Panetta,Mary V Relling,William E Evans,Nicolas Pottier,Meyling H Cheok,Wenjian Yang,Mahfoud Assem,Lorraine Tracey,John C Obenauer,John C Panetta,Mary V Relling,William E Evans,

Although cure rate of childhood acute lymphoblastic leukemia (ALL) has surpassed 80%, drug resistance remains a major cause of treatment failure. We previously identified a panel of 33 genes differentially expressed in prednisolone sensitive versus resistant ALL cells from newly diagnosed children. Here we used bioinformatics to identify resistance genes most likely to contain single nucleotide polymorphisms (SNPs) in their promoter region. The highest priority gene was SMARCB1, a core member of the SWI/SNF complex which promotes glucocorticoid effects through nucleosome remodeling. We identified several SNPs in the SMARCB1 promoter in lymphoblastoid cells from 90 individuals in the Centre d'Etude du Polymorphisme Humain (CEPH) panel. Among these SNPs, the -228G>T SNP (allele frequency 9.4%) was the only one that significantly increased reporter activity in human ALL cell lines. Furthermore, we identified nuclear protein poly (ADP-ribose) polymerase family, member 1 (PARP1) as a nuclear protein binding to the SMARCB1 promoter and showed that the -228 SNP significantly altered PARP1 binding affinity. The -228G>T SNP altered SMARCB1 mRNA and protein levels and a positive association was found between the SMARCB1 mRNA level and both the -228 genotype and prednisolone sensitivity in CEPH cell lines. Finally, knockdown experiments performed in human ALL cell lines confirmed that lower SMARCB1 expression increased prednisolone resistance. In summary, we provide functional evidence that SMARCB1 is involved in prednisolone resistance and identified a promoter SNP that alters the level of SMARCB1 mRNA and protein expression and the binding of PARP1 to the SMARCB1 promoter.

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Publishing Authors By Initials

N Pottier,MH Cheok,W Yang,M Assem,L Tracey,JC Obenauer,JC Panetta,MV Relling,WE Evans,N Pottier,MH Cheok,W Yang,M Assem,L Tracey,JC Obenauer,JC Panetta,MV Relling,WE Evans,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Human molecular genetics

VOLUME: 16

Page Numbers: 2261-71

Journal Abbreviation: Hum. Mol. Genet.

ISSN: 0964-6906

DAY: 5

MONTH: 07

YEAR: 2007

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9208958

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.

AFFILIATION: Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Country: England

AGENCY: United States NIGMS

GRANT: U01 GM61394

ACRONYM: GM

MEDLINETA: Hum Mol Genet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression Related Publications

• A national needs assessment of nurses providing health care to adolescents.
• Application of pharmacological principles to benzodiazepine therapy.
• Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation.
• Black-white differences in health-related quality of life among older adults.
• Cannabinoids: the separation of central from peripheral effects on a structural basis.
• Chiropractic clinical research: progress and recommendations.
• Determinants of cockroach and mouse exposure and associations with asthma in families and elderly individuals living in New York City public housing.
• Distinguishing product and practice regulation in personalized medicine.
• Duplex strand joining reactions catalyzed by vaccinia virus DNA polymerase.
• Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters.
• Embryo production from superovulated sheep inseminated with sex-sorted ram spermatozoa.
• Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.
• Homocysteine in health and disease.
• Is lower cognitive function in one spouse associated with depressive symptoms in the other spouse?
• Judith corker, 1967-1998.
• Maintenance of delay of gratification by four chimpanzees (Pan troglodytes): the effects of delayed reward visibility, experimenter presence, and extended delay intervals.
• Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.
• Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.
• Prodigious alcohol consumption by Australian rugby league footballers.
• Relative weight and mobility: a longitudinal study in a biracial population of older adults.
• STAT5 acts as a repressor to regulate early embryonic erythropoiesis.
• Serum estradiol-17beta concentrations during spontaneous silent estrus and after prostaglandin treatment in the mare.
• Smad1 expands the hemangioblast population within a limited developmental window.
• Strategies for treatment-resistant depression.
• Strategies for treatment-resistant depression.
• The acute effects of gabapentin in combination with alcohol in heavy drinkers.
• The effects of xylazine and alpha-adrenoreceptor antagonists on bovine uterine contractility in vitro.
• The evaluation of extracorporeal shock wave therapy on collagenase induced superficial digital flexor tendonitis.
• To the editor.
• Treatment approaches for interstitial cystitis: multimodality therapy.